The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Amsidine 75 mg/1.5 ml Concentrate and Solvent for Concentrate for Solution for Infusion



Eurocept International BVPA1591/002/001

Main Information

Trade NameAmsidine 75 mg/1.5 ml Concentrate and Solvent for Concentrate for Solution for Infusion
Active SubstancesAmsacrine
Dosage FormConcentrate and solvent for concentrate for solution for infusion
Licence HolderEurocept International BV
Licence NumberPA1591/002/001

Group Information

ATC CodeL01XX Other antineoplastic agents
L01XX01 amsacrine

Status

License statusAuthorised
Licence Issued17/08/2012
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back